Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,386 | 33,682 | 13,414 | 13,096 | 13,143 |
| Marketable Securities | 17,548 | N/A | N/A | 2,300 | 2,299 |
| Receivables | 66 | 5 | N/A | 50 | 25 |
| Other current assets | 1,521 | 1,035 | 226 | 455 | 508 |
| TOTAL | $35,521 | $34,722 | $13,640 | $15,901 | $15,975 |
| Non-Current Assets | |||||
| PPE Net | 94 | 114 | 137 | 157 | 182 |
| Investments And Advances | 1,914 | 7,333 | 7,117 | 7,117 | 7,185 |
| Intangibles | 3,208 | 3,208 | 3,208 | 3,208 | 3,208 |
| Other Non-Current Assets | 81 | 81 | 62 | 62 | 84 |
| TOTAL | $5,297 | $10,736 | $10,524 | $10,544 | $10,659 |
| Total Assets | $40,818 | $45,458 | $24,164 | $26,445 | $26,634 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,001 | 3,781 | 4,152 | 4,099 | 4,613 |
| Accrued Expenses | 755 | 2,371 | 714 | 143 | 496 |
| TOTAL | $6,032 | $6,428 | $5,022 | $5,826 | $6,693 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 156 | 156 | 156 | 1,464 | 1,464 |
| Other Non-Current Liabilities | 2,689 | 4,071 | 4,088 | 4,105 | 4,122 |
| TOTAL | $2,689 | $4,071 | $4,088 | $21,086 | $21,430 |
| Total Liabilities | $8,721 | $10,499 | $9,110 | $26,912 | $28,123 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,861 | 55,981 | 47,839 | 47,896 | 47,832 |
| Common Shares | 57 | 56 | 48 | 48 | 48 |
| Retained earnings | -321,433 | -316,775 | -317,335 | -331,467 | -331,918 |
| Other shareholders' equity | -177 | -107 | -357 | -357 | -357 |
| TOTAL | $32,097 | $34,959 | $15,054 | $-467 | $-1,489 |
| Total Liabilities And Equity | $40,818 | $45,458 | $24,164 | $26,445 | $26,634 |